Article Text

Download PDFPDF
Determination of the absolute perfusion threshold preventing myocardial ischaemia in humans
  1. R Vogel,
  2. A Indermühle,
  3. C Seiler
  1. Department of Cardiology, University Hospital Bern, Bern, Switzerland
  1. Correspondence to:
    Professor Christian Seiler
    Department of Cardiology, University Hospital Bern, CH-3010 Bern, Switzerland;christian.seiler{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The ischaemic cascade1 describes the temporal sequence of pathophysiological events initiated by an imbalance between myocardial oxygen supply and demand. Depending on severity and duration, an ischaemic episode may manifest as metabolic disturbance, mechanical dysfunction, electrical changes, angina pectoris or, ultimately, as myocardial infarction. Although being the primary sequelae of coronary artery disease (CAD), quantitative relationships between myocardial perfusion changes and their consequences such as metabolic, mechanical or electrical dysfunction are not well defined. In particular, the existence of an absolute perfusion threshold preventing short-term ischaemia has not been investigated so far.

Percutaneous coronary intervention (PCI) provides an elegant model to deal with this issue in patients with CAD. During angioplasty, myocardial blood supply is diminished below normal depending on the collateral supply from adjacent vascular regions. Absolute perfusion or myocardial blood flow (MBF, ml/min/g) can be obtained from positron emission tomography and, of late, from myocardial contrast echocardiography (MCE).2 However, only MCE is applicable during PCI owing to its mobility and short acquisition time.

Our study aimed to determine the absolute perfusion threshold that prevents myocardial ischaemia using MBF measurements by contrast echocardiography during angioplasty in humans.


Twenty eight consecutive patients with stable CAD eligible for PCI …

View Full Text


  • Funding: This work was supported by grants from the Swiss National Science Foundation (number 3200B0-100065) and the Swiss Heart Foundation.

  • Competing interests: None.